RGEN Share Price

Open 44.04 Change Price %
High 44.60 1 Day -0.06 -0.14
Low 43.50 1 Week -0.17 -0.38
Close 44.15 1 Month 2.21 5.27
Volume 141808 1 Year 11.35 34.60
52 Week High 46.81
52 Week Low 26.16
RGEN Important Levels
Resistance 2 45.17
Resistance 1 44.75
Pivot 44.08
Support 1 43.55
Support 2 43.13
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.02 100.00%
RITT 0.02 100.00%
LOCM 0.09 50.00%
SCHS 0.04 33.33%
GEVO 0.81 32.79%
MRGE 0.55 30.95%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CYCC 2.24 21.74%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Repligen Corporation (NASDAQ: RGEN)

RGEN Technical Analysis 4
As on 21st Sep 2017 RGEN Share Price closed @ 44.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 35.83 & Buy for SHORT-TERM with Stoploss of 42.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
RGEN Target for September
1st Target up-side 46.06
2nd Target up-side 47.73
3rd Target up-side 49.4
1st Target down-side 41.28
2nd Target down-side 39.61
3rd Target down-side 37.94
RGEN Other Details
Segment EQ
Market Capital 156846352.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.repligen.com
RGEN Address
RGEN
Building 1
Suite 100
Waltham, MA 02453
United States
Phone: 781-250-0111
Fax: 781-250-0115
RGEN Latest News
Interactive Technical Analysis Chart Repligen Corporation ( RGEN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Repligen Corporation
RGEN Business Profile
Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies several growth factor products used to increase cell culture productivity in biomanufacturing. The Company develops and markets a series of OPUS (Open Platform User Specified) single-use chromatography columns used in the biologics purification process.